Genfit Reports Strong Financial Performance in FY 2023
Friday, 5 April 2024, 12:28
Genfit FY Results
French biotech company Genfit reported €38.2 million in revenue for 2023, compared to €26.6 million in 2022, along with an EPS loss of €0.58.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.